Articles Mentioning Pharmaceuticals Stocks

Results 1 - 10 of 992 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals

Investing | December 08, 2016

What Happened to Marijuana Stocks in 2016?

It was a banner year for companies developing drugs associated with compounds found in marijuana.

Investing | December 07, 2016

Why AstraZeneca plc Stock Slumped in November

AstraZeneca's shares continued their downward spiral last month, falling by more than 8%.

Investing | November 29, 2016

The 5 Best Biotech Stocks of 2016

Here's how Axim Biotechnologies, CoLucid Pharmaceuticals, Corbus Pharmaceuticals, Exelixis, and Tesaro outperformed their peers this year, and their outlooks for 2017

Investing | November 28, 2016

3 Top Drug Stocks for Your Retirement Portfolio

If you're looking for stocks that combine solid dividends and growth potential, drugmakers Bristol-Myers Squibb, AbbVie, and Lilly might be right for you.

Investing | October 29, 2016

3 Things AbbVie's Management Said While Its Stock Got Hammered

AbbVie shares sank Friday on disappointing Q3 results. Here's what management had to say.

Investing | October 28, 2016

5 Things Amgen Inc.'s Management Wants You to Know

Here's what you need to know about what Amgen's management said in the biotech's Q3 earnings call.

Investing | October 21, 2016

Vanguard Healthcare Fund: 3 Things You Must Know Before Buying This Health Fund

Among medical mutual funds, the Vanguard Health Care Fund stands out for performance, low expenses, and its managers' buy-and-hold philosophy. But don't buy it just for the yield -- its high dividend is an illusion.

Investing | October 15, 2016

3 Incredibly Cheap Big Pharma Stocks

Looking for Big Pharma bargains? Mallinckrodt, Bayer, and Bristol-Myers Squibb might be right up your alley.

Investing | October 09, 2016

Which Big Pharma Is the Best Dividend Stock?

A look at the past, present, and future to determine which big pharma is the best dividend stock of them all.

Investing | October 07, 2016

Did Pfizer's No-Split Decision Cost Investors a Lot of Money?

Let Pfizer be Pfizer? Staying one company could be a bad move for shareholders.

Results 1 - 10 of 992 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals